SMTL ID : 6rwr.1

Engineered beta-lactoglobulin: variant M107L in complex with myristic acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

homo-dimer

Ligands

2 x MYR: MYRISTIC ACID(Non-covalent)

MYR.1: 12 residues within 4Å: Chain A: L.39, V.41, L.46, L.54, I.56, L.58, K.69, I.71, I.84, V.92, F.105, L.107 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.39, A:V.41, A:L.46, A:L.54, A:I.56, A:L.58, A:I.71, A:V.92, A:F.105, A:F.105, A:F.105, A:F.105, A:L.107 Salt bridges: A:K.69 MYR.2: 12 residues within 4Å: Chain B: L.39, V.41, L.46, L.54, I.56, L.58, K.69, I.71, I.84, V.92, F.105, L.107 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:L.39, B:V.41, B:L.46, B:L.54, B:I.56, B:L.58, B:I.71, B:V.92, B:F.105, B:F.105, B:F.105, B:F.105, B:L.107 Salt bridges: B:K.69

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bonarek, P. et al., Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol. (2020)

Release Date

2019-06-19

Peptides

Beta-lactoglobulin: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Beta-lactoglobulin

Related Entries With Identical Sequence